214 related articles for article (PubMed ID: 24566899)
1. ARID1A is downregulated in non-small cell lung cancer and regulates cell proliferation and apoptosis.
Zhang Y; Xu X; Zhang M; Bai X; Li H; Kan L; Niu H; He P
Tumour Biol; 2014 Jun; 35(6):5701-7. PubMed ID: 24566899
[TBL] [Abstract][Full Text] [Related]
2. Decreased ARID1A expression facilitates cell proliferation and inhibits 5-fluorouracil-induced apoptosis in colorectal carcinoma.
Xie C; Fu L; Han Y; Li Q; Wang E
Tumour Biol; 2014 Aug; 35(8):7921-7. PubMed ID: 24833095
[TBL] [Abstract][Full Text] [Related]
3. LRRC3B is downregulated in non-small-cell lung cancer and inhibits cancer cell proliferation and invasion.
Kan L; Li H; Zhang Y; Wang J; Niu H; Jiang H; Zhang M; Bai X; He P
Tumour Biol; 2016 Jan; 37(1):1113-20. PubMed ID: 26276358
[TBL] [Abstract][Full Text] [Related]
4. TRIM31 is downregulated in non-small cell lung cancer and serves as a potential tumor suppressor.
Li H; Zhang Y; Zhang Y; Bai X; Peng Y; He P
Tumour Biol; 2014 Jun; 35(6):5747-52. PubMed ID: 24566900
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
[TBL] [Abstract][Full Text] [Related]
6. Silencing the FOLR2 Gene Inhibits Cell Proliferation and Increases Apoptosis in the NCI-H1650 Non-Small Cell Lung Cancer Cell Line via Inhibition of AKT/Mammalian Target of Rapamycin (mTOR)/Ribosomal Protein S6 Kinase 1 (S6K1) Signaling.
Xu X; Jiang J; Yao L; Ji B
Med Sci Monit; 2018 Nov; 24():8064-8073. PubMed ID: 30415267
[TBL] [Abstract][Full Text] [Related]
7. PLAU promotes growth and attenuates cisplatin chemosensitivity in ARID1A-depleted non-small cell lung cancer through interaction with TM4SF1.
Zheng Y; Zhang L; Zhang K; Wu S; Wang C; Huang R; Liao H
Biol Direct; 2024 Jan; 19(1):7. PubMed ID: 38229120
[TBL] [Abstract][Full Text] [Related]
8. Ataxia-telangiectasia group D complementing gene (ATDC) promotes lung cancer cell proliferation by activating NF-κB pathway.
Tang ZP; Dong QZ; Cui QZ; Papavassiliou P; Wang ED; Wang EH
PLoS One; 2013; 8(6):e63676. PubMed ID: 23776433
[TBL] [Abstract][Full Text] [Related]
9. ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers.
Guan B; Wang TL; Shih IeM
Cancer Res; 2011 Nov; 71(21):6718-27. PubMed ID: 21900401
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of CRKL correlates with poor prognosis and cell proliferation in non-small cell lung cancer.
Wang Y; Dong QZ; Fu L; Stoecker M; Wang E; Wang EH
Mol Carcinog; 2013 Nov; 52(11):890-9. PubMed ID: 22753141
[TBL] [Abstract][Full Text] [Related]
11. Rab11a promotes proliferation and invasion through regulation of YAP in non-small cell lung cancer.
Dong Q; Fu L; Zhao Y; Du Y; Li Q; Qiu X; Wang E
Oncotarget; 2017 Apr; 8(17):27800-27811. PubMed ID: 28468127
[TBL] [Abstract][Full Text] [Related]
12. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
13. PEBP4 enhanced HCC827 cell proliferation and invasion ability and inhibited apoptosis.
Yu G; Shen Z; Chen G; Teng X; Hu Y; Huang B
Tumour Biol; 2013 Feb; 34(1):91-8. PubMed ID: 22983920
[TBL] [Abstract][Full Text] [Related]
14. Chromatin remodeling gene AT-rich interactive domain-containing protein 1A suppresses gastric cancer cell proliferation by targeting PIK3CA and PDK1.
Zhang Q; Yan HB; Wang J; Cui SJ; Wang XQ; Jiang YH; Feng L; Yang PY; Liu F
Oncotarget; 2016 Jul; 7(29):46127-46141. PubMed ID: 27323812
[TBL] [Abstract][Full Text] [Related]
15. Loss of ARID1A expression is associated with poor prognosis in non-small cell lung cancer.
Jang SH; Lee JH; Lee HJ; Cho H; Ahn H; Song IH; Oh MH
Pathol Res Pract; 2020 Nov; 216(11):153156. PubMed ID: 32823232
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer.
Wang Y; Dong Q; Zhang Q; Li Z; Wang E; Qiu X
Cancer Sci; 2010 May; 101(5):1279-85. PubMed ID: 20219076
[TBL] [Abstract][Full Text] [Related]
17. The transcription factor DEC1 (BHLHE40/STRA13/SHARP-2) is negatively associated with TNM stage in non-small-cell lung cancer and inhibits the proliferation through cyclin D1 in A549 and BE1 cells.
Liu Y; Wang L; Lin XY; Wang J; Yu JH; Miao Y; Wang EH
Tumour Biol; 2013 Jun; 34(3):1641-50. PubMed ID: 23423709
[TBL] [Abstract][Full Text] [Related]
18. Delphinidin reduces cell proliferation and induces apoptosis of non-small-cell lung cancer cells by targeting EGFR/VEGFR2 signaling pathways.
Pal HC; Sharma S; Strickland LR; Agarwal J; Athar M; Elmets CA; Afaq F
PLoS One; 2013; 8(10):e77270. PubMed ID: 24124611
[TBL] [Abstract][Full Text] [Related]
19. Hes3 Enhances the Malignant Phenotype of Lung Cancer through Upregulating Cyclin D1, Cyclin D3 and MMP7 Expression.
Fang C; Jiang B; Shi X; Fan C
Int J Med Sci; 2019; 16(3):470-476. PubMed ID: 30911281
[No Abstract] [Full Text] [Related]
20. LncRNA HULC promotes non-small cell lung cancer cell proliferation and inhibits the apoptosis by up-regulating sphingosine kinase 1 (SPHK1) and its downstream PI3K/Akt pathway.
Liu L; Zhou XY; Zhang JQ; Wang GG; He J; Chen YY; Huang C; Li L; Li SQ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8722-8730. PubMed ID: 30575912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
